首页> 外文OA文献 >The synergistic antitumor effect of combined Anti-Human Epidermal Growth Factor Receptor 2 (HER2) antibody and Gamma Interferon therapy to Ab resistant breast cancer cells

【2h】

The synergistic antitumor effect of combined Anti-Human Epidermal Growth Factor Receptor 2 (HER2) antibody and Gamma Interferon therapy to Ab resistant breast cancer cells

机译：联合抗人体表皮生长因子受体2（HER2）抗体和γ干扰素治疗与AB抗性乳腺癌细胞的协同抗肿瘤效应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Toshihiko Gocho; Hiromichi Tsuchiya; Shotaro Kamijo; Yoshitaka Yamazaki; Yui Akita; Akiko Sasaki; Yuji Kiuchi;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status [J] . Nuciforo P. G., Aura C., Holmes E., Annals of oncology: official journal of the European Society for Medical Oncology . 2015,第7期

机译：对HER2阳性原发性乳腺癌中新辅助抗人表皮生长因子受体2（HER2）靶向疗法的益处独立于从10号染色体（PTEN）状态中删除的磷酸酶和肌腱同源物
2. Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status [J] . Nuciforo P. G., Aura C., Holmes E., Annals of oncology: official journal of the European Society for Medical Oncology . 2015,第7期

机译：对新辅助的抗人体表皮生长因子受体2（HER2）在HER2阳性乳腺癌中的疗法效应是独立于从染色体10（PTEN）状态缺失的磷酸酶和Tensin Homolog
3. PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer [J] . LoiblS., VonMinckwitzG., SchneeweissA., Journal of Clinical Oncology . 2014,第29期

机译：PIK3CA突变与原发性HER2过表达的乳腺癌对抗人表皮生长因子受体2（HER2）治疗的病理完全缓解率降低相关
4. Combination of Novel HER2 Targeting Antibody 1A12 with Trastuzumab Shows Synergistic Antitumor Activity in HER2 Positive Gastric Cancer [C] . Kyu-Tae Kim, Jong-Seo Lee, Ki-Hyun Kim, PEGS . 2015

机译：具有曲妥珠单抗的新型HER2靶向抗体1a12的组合在HER2阳性胃癌中显示了协同抗肿瘤活性
5. Indirect Costs Associated with Human Epidermal Growth Factor Receptor Positive (HER2+) Metastatic Breast Cancer [D] . Wright, Phoebe. 2020

机译：与人表皮生长因子受体阳性（HER2 +）转移性乳腺癌相关的间接成本
6. Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers [O] . Takuya Osada, Zachary C. Hartman, Junping Wei, 2018

机译：HER3疫苗诱导的多功能抗人表皮生长因子受体3（anti-HER3）抗体具有多种抗肿瘤活性可抵抗治疗性耐药和三阴性乳腺癌
7. Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers [O] . Takuya Osada, Zachary C. Hartman, Junping Wei, 2018

机译：由HER3疫苗诱导的多官能抗人表皮生长因子受体3（抗HER3）抗体具有对治疗抗性和三重阴性乳腺癌的抗肿瘤活性的多种机制

The synergistic antitumor effect of combined Anti-Human Epidermal Growth Factor Receptor 2 (HER2) antibody and Gamma Interferon therapy to Ab resistant breast cancer cells

著录项

引文网络

相似文献

相关主题

期刊订阅